Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028337 · ClinicalTrials.gov registry record · Phase 2
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
A Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03028337: Active Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, sponsored by M.D. Anderson Cancer Center.
NCT03028337 is a Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028337, a Phase 2 study of Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain, and quality-of-life.
Primary Outcome
Local failure determined based on the surveillance MRI scan by study musculoskeletal radiologist.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- RADIATION Spine Radiosurgery
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2028-05-30 |
| Phase | Phase 2 |
What the registry record for NCT03028337 still lists
NCT03028337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03028337 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03028337 about?
NCT03028337 is a clinical study titled "Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases". The goal of this clinical research study is to learn whether delivering spine radiosurgery in a single large dose is better than delivering spine radiosurgery over 3 smaller doses. Researchers also want to learn about the effects of a single dose on participant's symptoms, pain, and quality-of-life...
What is the current status of trial NCT03028337?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2017-01-18. Estimated completion is 2028-05-30.
What conditions does trial NCT03028337 study?
This clinical trial studies the following conditions: Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System.
What interventions are being tested in trial NCT03028337?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Spine Radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT03028337?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03028337 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03028337's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI